Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 482,949 |
|
|||||
| News | - | ||||||
| Day High | 14.28 | Low High |
|||||
| Day Low | 13.29 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cabaletta Bio Inc | CABA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.611 | -4.37% | 13.359 | 14:22:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.90 | 13.29 | 14.28 | 13.97 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,010 | 482,949 | $ 13.71 | $ 6,621,013 | - | 7.69 - 26.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:22:01 | 100 | $ 13.359 | USD |
Cabaletta Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 572.9M | 42.85M | - | 0 | -67.68M | -1.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cabaletta Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CABA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.74 | 18.44 | 13.255 | 15.62 | 986,559 | -4.38 | -24.70% |
| 1 Month | 16.91 | 19.04 | 13.255 | 16.80 | 1,009,785 | -3.55 | -21.00% |
| 3 Months | 22.35 | 26.35 | 13.255 | 20.05 | 971,400 | -8.99 | -40.23% |
| 6 Months | 14.00 | 26.35 | 9.55 | 18.61 | 1,083,618 | -0.641 | -4.58% |
| 1 Year | 8.43 | 26.35 | 7.69 | 16.88 | 835,556 | 4.93 | 58.47% |
| 3 Years | 10.66 | 26.35 | 0.59 | 9.54 | 655,554 | 2.70 | 25.32% |
| 5 Years | 9.45 | 26.35 | 0.59 | 9.67 | 471,818 | 3.91 | 41.37% |
Cabaletta Bio Description
| Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAAR, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CAAR T cell product candidate was designed based on the clinically validated and commercially approved Chimeric Antigen Receptor, or CAR, T cell technology that is marketed for the treatment of B cell cancers. |
